Resources
Filters
Precision recruitment for high-risk participants in a COVID-19 cohort study
Precision recruitment for high-risk participants in a COVID-19 cohort study
Precision recruitment for high-risk participants in a COVID-19 cohort study
-pages-01.avif)
Precision recruitment for high-risk participants in a COVID-19 cohort study
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
New AI-enabled data collection platform will drive the development of novel multimodal datasets for biomarker discovery, treatment-response modeling, and foundation models of the immune system.
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
New insights from Evidation’s cardiometabolic health and weight management cohort, comprised of over 160,000 individuals, show what factors shape real-world dosing decisions.
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer. Dr. Khan will advance Evidation’s leadership in real-world data by driving the clinical strategy for direct-to-participant multimodal data collection to fuel AI-powered discovery and evidence generation.
A New Model for Real-World Data in Weight and Metabolic Health
A New Model for Real-World Data in Weight and Metabolic Health
A New Model for Real-World Data in Weight and Metabolic Health
A New Model for Real-World Data in Weight and Metabolic Health
Evidation’s BODEE-Weight Study recruited nearly 500 adults with BMI ≥25 in three weeks, pairing self-report, wearables, and EHR data to deliver a new interactive model for real-world evidence.
Measuring Real-World Cardiometabolic Health Using Wearable-Derived Data
Measuring Real-World Cardiometabolic Health Using Wearable-Derived Data
Measuring Real-World Cardiometabolic Health Using Wearable-Derived Data
Measuring Real-World Cardiometabolic Health Using Wearable-Derived Data
Evidation's cardiometabolic score, developed through wearable derived data, can reveal subtle shifts in health that precede clinical diagnosis, offering a scalable, privacy-centric way to assess risk, monitor change, and engage individuals.
Evidation Appoints Leslie Oley Wilberforce as CEO
Evidation Appoints Leslie Oley Wilberforce as CEO
Evidation Appoints Leslie Oley Wilberforce as CEO
Evidation Appoints Leslie Oley Wilberforce as CEO
Evidation appoints Leslie Oley Wilberforce as CEO. Wilberforce will lead Evidation’s next phase of growth in interactive real-world data and health research.
GLP-1s: Real-world insights from 10,000 users
GLP-1s: Real-world insights from 10,000 users
GLP-1s: Real-world insights from 10,000 users
GLP-1s: Real-world insights from 10,000 users
Evidation's direct-to-participant connection is reshaping real-world insights into weight management journeys and GLP-1 usage. Explore what's possible with interactive real-world data collected directly from 10,000+ people using GLP-1s.
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
Leveraging Real-World Data: Insights into Depression from Surveys and Wearables
A continuous, direct connection to an online community of engaged individuals willing to respond to surveys and connect their devices and apps, such as Apple Watches and Fitbits, presents opportunities to capture data longitudinally. These novel, layered datasets help accurately and comprehensively describe the real-world experiences with depression and psycho- and pharmacotherapy.
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation appoints Phil Johnson as Chief Commercial Officer
Evidation announces the addition of a new Chief Commercial Officer, Phil Johnson, and board member, Ian Lennox.
No results found. Try broadening your search for more results!